ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Glaukos Corporation (GKOS)

NYSE

$112.56

$-1.00

(-0.88%)

Glaukos Corporation (GKOS) Live Price Chart

Page last updated: 2026-02-06 21:10:00

Key Market Data

Market Cap	$6.46B
Open	$114.37
High	$163.71
Low	$14.25
Previous Close	$113.52
Price Change	$-1.00
Percentage Change	-0.88%
Volume	952K

Glaukos Corporation (GKOS) Stock Price Today

Glaukos Corporation (GKOS) is currently trading at $112.56 as of 2026-02-06 21:10:00, reflecting a -0.88% move ($-1.00) from the previous close.

In the short term, the stock has returned -139.29% over the past four weeks. Over the last 12 months, Glaukos Corporation has recorded a -27.51% price change, indicating a weak performance relative to the broader market.

Glaukos Corporation (GKOS) 7-Day Stock Price Changes

Over the past seven days, Glaukos Corporation has traded within a short-term range shaped by market sentiment in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. During this period, the stock moved from its previous closing price of $119.64 to the latest recorded price of $112.56, reflecting an intraday change of -0.88%. Daily movements highlight shifts in trading volume (951,647), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, GKOS has delivered a -139.29% return over the past month and a -27.51% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Glaukos Corporation (GKOS)

You can buy and trade GKOS on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for GKOS and Execute Your Trade

Open the trading page, enter GKOS in the search bar, select the amount of GKOS you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Glaukos Corporation (GKOS)?

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Glaukos Corporation Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	995
Sector	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Website	https://www.glaukos.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Glaukos Corporation?

The latest trading price for Glaukos Corporation (Common Stock) is $ 112.56, compared with a previous closing price of $ 113.52. That means the stock has moved -0.88% so far today. Intraday price updates and recent trading activity for GKOS can be tracked on the live chart and quote section on this page.

2.Is Glaukos Corporation stock going up or down?

Looking at recent performances, GKOS has returned -139.29% over the past month, +29.35% over the last six months and -27.51% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Glaukos Corporation stock, but keep in mind that past returns do not guarantee future results.

3.Where does GKOS currently sit relative to its 52-week high and low?

In the most recent 52-week period, Glaukos Corporation has traded between a low of $ 73.16 and a high of $ 161.78. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether GKOS is currently nearer the top or the bottom of its one-year trading band.

4.How is Glaukos Corporation classified by sector and industry?

Glaukos Corporation is classified in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, within the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry group and the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. In practice, this means Glaukos Corporation is grouped with companies that face similar end-markets, competitive dynamics and regulatory environments. For investors, knowing GKOS's sector and industry classification helps when building diversified portfolios, comparing Glaukos Corporation with direct peers, and understanding how stock-specific risks such as -- may be influenced by broader trends in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

5.Where is Glaukos Corporation listed and how large is it by market value?

Glaukos Corporation is listed on the NYSE stock exchange in United States. Based on a market capitalization of $ 6.46B, the company is classified as a Mid-cap stock. Market cap gives a quick sense of Glaukos Corporation's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does GKOS's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -1.53 summarises how much profit Glaukos Corporation has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Glaukos Corporation's financial performance over time?

To follow Glaukos Corporation's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how GKOS is performing and how the market is responding.

8.When is Glaukos Corporation expected to report earnings?

Glaukos Corporation's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for GKOS, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Glaukos Corporation's earnings reports?

Glaukos Corporation's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether GKOS is meeting, beating or missing expectations.

10.How can I stay informed about Glaukos Corporation's results and guidance?

You can stay up to date on Glaukos Corporation by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for GKOS on this page helps you see how new information is being reflected in the stock.

11.Does Glaukos Corporation pay a regular cash dividend to its shareholders?

Glaukos Corporation Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor GKOS's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for GKOS?

Based on the latest earnings data, GKOS has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Glaukos Corporation is an attractive income stock. The dividend payout ratio measures what percentage of earnings Glaukos Corporation distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Glaukos Corporation?

Glaukos Corporation is a publicly traded company in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry within the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is GKOS valued in terms of P/E ratio and EPS?

Glaukos Corporation currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -1.53. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Glaukos Corporation's earnings. Comparing GKOS's P/E and EPS to those of other SURGICAL & MEDICAL INSTRUMENTS & APPARATUS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Glaukos Corporation

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

American Express Company

AXP

CHEGG, INC.

CHGG

The Estee Lauder Companies Inc.

Home Depot, Inc.

Huntington Ingalls Industries, Inc.

HII

Top Gainers

Browse today's leading gainers in the US stock market

TuHURA Biosciences, Inc.

HURA

Liberty Global Ltd

LBTYB

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

GKOS-to-USD Calculator

Amount

GKOS

USD

1 GKOS = 112.56 USD